Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers

T Vesikari; A Forstén; D Boutriau

doi:10.4161/hv.22166

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers

T Vesikari, A Forstén, D Boutriau

Department of Paediatrics

Research output: Contribution to journal › Article › Scientific › peer-review

30 Citations (Scopus)

Original language	English
Pages (from-to)	1892-1903
Journal	HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume	8
Issue number	12
DOIs	https://doi.org/10.4161/hv.22166
Publication status	Published - 2012
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/hv.22166

Cite this

@article{74af29302ab0490287d08b1f3a31091a,

title = "Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers",

author = "T Vesikari and A Forst{\'e}n and D Boutriau",

year = "2012",

doi = "10.4161/hv.22166",

language = "English",

volume = "8",

pages = "1892--1903",

journal = "HUMAN VACCINES & IMMUNOTHERAPEUTICS",

issn = "2164-5515",

number = "12",

}

Vesikari, T, Forstén, A & Boutriau, D 2012, 'Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers', HUMAN VACCINES & IMMUNOTHERAPEUTICS, vol. 8, no. 12, pp. 1892-1903. https://doi.org/10.4161/hv.22166

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers. / Vesikari, T; Forstén, A; Boutriau, D.
In: HUMAN VACCINES & IMMUNOTHERAPEUTICS, Vol. 8, No. 12, 2012, p. 1892-1903.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers

AU - Vesikari, T

AU - Forstén, A

AU - Boutriau, D

PY - 2012

Y1 - 2012

U2 - 10.4161/hv.22166

DO - 10.4161/hv.22166

M3 - Article

SN - 2164-5515

VL - 8

SP - 1892

EP - 1903

JO - HUMAN VACCINES & IMMUNOTHERAPEUTICS

JF - HUMAN VACCINES & IMMUNOTHERAPEUTICS

IS - 12

ER -